Stonepine Capital
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 15, 2020
Kineta (Reverse Merger With Yumanity Therapeutics)
|
Series Unknown | $33.59M | Biotechnology | — |
May 27, 2015
Viveve
|
Post-IPO Equity | $12M | Hardware | Yes |
Mar 9, 2015
Tobira Therapeutics
|
Convertable Note | $13M | Biotechnology | — |
Stonepine Capital has had 3 exits. Stonepine Capital most notable exits include Kineta (Reverse Merger With Yumanity Therapeutics) , Viveve
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 23, 2020 | Kineta (Reverse Merger With Yumanity Therapeutics) | M&A | Biotechnology | Detail |
Jun 13, 2016 | Viveve | M&A | Hardware | Detail |
May 5, 2015 | Tobira Therapeutics | M&A | Biotechnology | Detail |